Literature DB >> 29554554

Predominant subcortical accumulation of 18F-flortaucipir binding in behavioral variant frontotemporal dementia.

Hanna Cho1, Sang Won Seo2, Jae Yong Choi3, Hye Sun Lee4, Young Hoon Ryu5, Myung Sik Lee1, Duk L Na2, Hee Jin Kim6, Chul Hyoung Lyoo7.   

Abstract

Behavioral variant frontotemporal dementia (bvFTD) is the most common form of frontotemporal dementia, and tau pathology can be found in 40%-50% of bvFTD patients. In this study, we sought to investigate 18F-flortaucipir-binding patterns and their correlates in clinically diagnosed bvFTD patients by comparing with results for Alzheimer's disease (AD) patients. We enrolled 20 bvFTD, 20 AD, and 20 age-matched healthy subjects who underwent neuropsychological tests, magnetic resonance imaging, and tau positron emission tomography scans with 18F-flortaucipir. Regional standardized uptake value ratios for the cerebral cortex and underlying white matter were compared between the 2 groups. The bvFTD patients showed increased 18F-flortaucipir binding in the putamen and globus pallidus when compared to the healthy controls. In addition, bvFTD was associated with increased binding in the white matter regions underlying the frontal, anterior cingulate, and insula cortices. The bvFTD patients may exhibit predominantly subcortical 18F-flortaucipir-binding pattern that is distinct from the patterns seen in AD patients. We hypothesize that the clinical characteristics of bvFTD patients may be attributable to the dysfunctional frontal-subcortical networks. However, concerns remain regarding unknown "off-target" binding in the white matter and the basal ganglia.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  (18)F-flortaucipir; Behavioral variant frontotemporal dementia; Positron emission tomography; Tau

Mesh:

Substances:

Year:  2018        PMID: 29554554     DOI: 10.1016/j.neurobiolaging.2018.02.015

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  7 in total

1.  [18F]-AV-1451 tau PET imaging in Alzheimer's disease and suspected non-AD tauopathies using a late acquisition time window.

Authors:  Julien Lagarde; Pauline Olivieri; Fabien Caillé; Philippe Gervais; Jean-Claude Baron; Michel Bottlaender; Marie Sarazin
Journal:  J Neurol       Date:  2019-09-18       Impact factor: 4.849

Review 2.  FTD spectrum: Neuroimaging across the FTD spectrum.

Authors:  Jennifer L Whitwell
Journal:  Prog Mol Biol Transl Sci       Date:  2019-06-18       Impact factor: 3.622

Review 3.  Overview of tau PET molecular imaging.

Authors:  Gabriel Cassinelli Petersen; Michelle Roytman; Gloria C Chiang; Yi Li; Marc L Gordon; Ana M Franceschi
Journal:  Curr Opin Neurol       Date:  2022-04-01       Impact factor: 6.283

4.  18F-THK5351 PET Imaging in the Behavioral Variant of Frontotemporal Dementia.

Authors:  Gijin Nam; Hye Jin Jeong; Jae Myeong Kang; Sang-Yoon Lee; Seongho Seo; Ha-Eun Seo; Kee Hyung Park; Byeong Kil Yeon; Tatsuo Ido; Dong Jin Shin; Young Noh
Journal:  Dement Neurocogn Disord       Date:  2019-02-01

5.  Psychometric properties of Cognitive Instruments in Vascular Dementia and Alzheimer's disease: a neuropsychological study.

Authors:  Juliana Francisca Cecato; Everton Balduino; Débora Fuentes; José Eduardo Martinelli
Journal:  Clinics (Sao Paulo)       Date:  2020-03-09       Impact factor: 2.365

Review 6.  Neuroimaging in Frontotemporal Dementia: Heterogeneity and Relationships with Underlying Neuropathology.

Authors:  Bradley T Peet; Salvatore Spina; Nidhi Mundada; Renaud La Joie
Journal:  Neurotherapeutics       Date:  2021-08-13       Impact factor: 7.620

7.  [18F]Flortaucipir PET Across Various MAPT Mutations in Presymptomatic and Symptomatic Carriers.

Authors:  Emma E Wolters; Janne M Papma; Sander C J Verfaillie; Denise Visser; Emma Weltings; Colin Groot; Emma L van der Ende; Lucia A A Giannini; Hayel Tuncel; Tessa Timmers; Ronald Boellaard; Maqsood Yaqub; Danielle M E van Assema; Dennis A Kuijper; Marcel Segbers; Annemieke J M Rozemuller; Frederik Barkhof; Albert D Windhorst; Wiesje M van der Flier; Yolande A L Pijnenburg; Philip Scheltens; Bart N M van Berckel; John C van Swieten; Rik Ossenkoppele; Harro Seelaar
Journal:  Neurology       Date:  2021-07-01       Impact factor: 9.910

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.